LPL Financial’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $891K | Sell |
71,689
-3,126
| -4% | -$42K | ﹤0.01% | 4279 |
|
|
2025
Q4 | $943K | Sell |
74,815
-10,576
| -12% | -$121K | ﹤0.01% | 4130 |
|
|
2025
Q3 | $855K | Sell |
85,391
-2,989
| -3% | -$26.8K | ﹤0.01% | 4146 |
|
|
2025
Q2 | $715K | Buy |
88,380
+1,748
| +2% | +$13.2K | ﹤0.01% | 4062 |
|
|
2025
Q1 | $726K | Sell |
86,632
-16,333
| -16% | -$136K | ﹤0.01% | 3815 |
|
|
2024
Q4 | $815K | Buy |
102,965
+10,093
| +11% | +$84.7K | ﹤0.01% | 3676 |
|
|
2024
Q3 | $773K | Buy |
92,872
+20,834
| +29% | +$163K | ﹤0.01% | 3631 |
|
|
2024
Q2 | $457K | Sell |
72,038
-3,853
| -5% | -$24.5K | ﹤0.01% | 3945 |
|
|
2024
Q1 | $460K | Buy |
75,891
+10,470
| +16% | +$59K | ﹤0.01% | 3858 |
|
|
2023
Q4 | $397K | Buy |
65,421
+1,201
| +2% | +$5.35K | ﹤0.01% | 3850 |
|
|
2023
Q3 | $271K | Buy |
64,220
+5,997
| +10% | +$22.4K | ﹤0.01% | 4006 |
|
|
2023
Q2 | $180K | Sell |
58,223
-159
| -0.3% | -$339 | ﹤0.01% | 4186 |
|
|
2023
Q1 | $81.2K | Buy |
58,382
+2,635
| +5% | +$5.25K | ﹤0.01% | 4244 |
|
|
2022
Q4 | $111K | Buy |
55,747
+9,629
| +21% | +$21.6K | ﹤0.01% | 4142 |
|
|
2022
Q3 | $93K | Buy |
46,118
+8,783
| +24% | +$24.6K | ﹤0.01% | 4124 |
|
|
2022
Q2 | $119K | Buy |
37,335
+1,358
| +4% | +$4.92K | ﹤0.01% | 4092 |
|
|
2022
Q1 | $150K | Sell |
35,977
-5,798
| -14% | -$25.7K | ﹤0.01% | 3899 |
|
|
2021
Q4 | $200K | Buy |
41,775
+3,147
| +8% | +$15.7K | ﹤0.01% | 3983 |
|
|
2021
Q3 | $206K | Buy |
38,628
+6,006
| +18% | +$30.2K | ﹤0.01% | 3961 |
|
|
2021
Q2 | $167K | Buy |
32,622
+2,383
| +8% | +$13.5K | ﹤0.01% | 3956 |
|
|
2021
Q1 | $204K | Buy |
30,239
+6,604
| +28% | +$36.6K | ﹤0.01% | 3754 |
|
|
2020
Q4 | $108K | Buy |
23,635
+6,775
| +40% | +$30K | ﹤0.01% | 3667 |
|
|
2020
Q3 | $65K | Buy |
+16,860
| New | +$72.1K | ﹤0.01% | 3413 |
|
Other funds holding AMRX
TGA
VPM
RCMNY
VCM
